Welcome to the Femarelle® line site.

Femarelle® is the most recommended non-hormonal option by leading gynecologists around the world. Backed by science and sales of millions of units to date, the Femarelle line provides women around the globe a safe and effective option to alleviate their menopausal symptoms.

Please click on "Find Your Match" and together we will be able to find the Femarelle® most suitable to your needs in order to provide YOU prolonged quality of life.

click-here-to
Testimonials
  • Mrs. Merethe Mikkelsen, Norwegian Musician in the US

    I just wanted to thank you! I’m a jazz musician living in LA, USA and have had a tough time

    Mrs. Merethe Mikkelsen, Norwegian Musician in the US

  • Mrs. Merethe Mikkelsen, Norwegian Musician in the US

    from joint pain; it was not only painful but also embarrassing as I, after hours in the car,

    Mrs. Merethe Mikkelsen, Norwegian Musician in the US

  • Mrs. Jane Markov, Ridgefield, NJ, USA

    I thank you, makers of Femarelle! … I was suffering from menopausal symptoms, what misery.

    Mrs. Jane Markov, Ridgefield, NJ, USA

  • Jonah, Somerset, UK, 14 April 2015

    How to even out the ups and downs of the menopause rollercoaster in one fell swoop: take two Femarelle capsules

    Jonah, Somerset, UK, 14 April 2015

  • Articles
  • “DT56a decreased menopausal symptoms significantly and in the same degree as HT.”

    J Endocrinol Invest. 36(7):521-6

  • ” DT56a was effective against symptomatic vulvo-vaginal atrophy (vaginal dryness)…”

    NAMS Annual Congress 2011, book of abstracts

  • “Femarelle … inhibits menopausal symptoms without thrombogenicity…”

    Menopause 2011;18(3):285-288

  • “DT56a prevents postmenopausal osteoporosis.”

    BJOG. 2005;112(7):981-5

  • “Treatment with DT56a resulted in a significant reduction in the number and intensity of hot flushes in postmenopausal women… observed within the

    Climacteric. 2015;18(6):813-6

  • “DT56a … unique nature compared to the compounds currently used for postmenopausal osteoporosis by being bone-forming and not only an anti-resorptive

    J Steroid Biochem Mol Biol.. 2006;98(1):90-6

  • “Femarelle treatment in postmenopausal women increases BMD without unwanted estrogenic effect.”

    Menopause. 2003;10(6):522-5.

  • ” …significant reduction in the Kupperman index following 12 weeks of treatment, which was sustained throughout the 12 months of

    Clin. and Exp. Ob. & Gyne. 2004;31(2):123-6.

  • “DT56a has anti-estrogenic properties in the breast tissue…”

    Eur J Obstet Gynecol Reprod Biol. 2007;130(1):140-1.

  • Contact us

    Get Updates